Heather Bresch, chief executive officer of Mylan Inc., speaks during an interview in New York, U.S., on Thursday, May 1, 2014. Bresch discussed the U.S. corporate tax code and the impact of consolidation in the pharmaceutical industry on generic drugmakers like Mylan. Photographer: Chris Goodney/Bloomberg via Getty Images